Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?

Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia

(2013) Monika Sarkar et al.   ANNALS OF INTERNAL MEDICINE

Dyspeptic Symptom Development After Discontinuation of a Proton Pump Inhibitor: A Double-Blind Placebo-Controlled Trial

(2010) Anna Niklasson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women

(2010) Shelly L. Gray   ARCHIVES OF INTERNAL MEDICINE

Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events

(2010) James M. Scheiman et al.   CLINICAL THERAPEUTICS

Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients

(2010) Douglas A. Corley et al.   GASTROENTEROLOGY

Safety of Proton Pump Inhibitor Exposure

(2010) Yu–Xiao Yang et al.   GASTROENTEROLOGY

Clopidogrel with or without Omeprazole in Coronary Artery Disease

(2010) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

(2010) S. Pouwels et al.   OSTEOPOROSIS INTERNATIONAL

Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study

(2010) Hui-Fen Chiu et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief

(2009) C. W. HOWDEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis

(2009) D. C. METZ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy

(2009) Christina Reimer et al.   GASTROENTEROLOGY

Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss

(2009) Laura E. Targownik et al.   GASTROENTEROLOGY

Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates

(2009) F. de Vries et al.   OSTEOPOROSIS INTERNATIONAL

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel

(2008) Jolanta M. Siller-Matula et al.   AMERICAN HEART JOURNAL

Proton Pump Inhibitors and the Risk of Colorectal Cancer

(2008) Eva M. van Soest et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor forClostridium Difficile-Associated Diarrhea in Hospitalized Patients

(2008) Mohammed Aseeri et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Use of proton pump inhibitors and risk of osteoporosis-related fractures

(2008) L. E. Targownik et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Proton pump inhibitors: an update of their clinical use and pharmacokinetics

(2008) Shaojun Shi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease

(2008) Peter J. Kahrilas et al.   GASTROENTEROLOGY

American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease

(2008) Peter J. Kahrilas et al.   GASTROENTEROLOGY

Control of Gastric Acid Secretion in Health and Disease

(2008) Mitchell L. Schubert et al.   GASTROENTEROLOGY

Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel

(2008) David S. Small et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

(2008) Martine Gilard et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors

(2008) James A Kaye et al.   PHARMACOTHERAPY